FTC Announces New Health Care Task Force

April 3, 2026 - 01:16

In a significant move to increase regulatory oversight, the Federal Trade Commission has established a new task force dedicated to investigating antitrust violations across the health care industry. The multi-disciplinary team will scrutinize mergers, acquisitions, and conduct within the sector, signaling a more aggressive enforcement posture.

The initiative, announced by FTC leadership, will leverage legal expertise, economic analysis, and data science to examine potentially anti-competitive practices. The focus will extend beyond hospital systems to include pharmaceutical companies, pharmacy benefit managers, and other key players. Officials stated the goal is to ensure robust competition, which they argue is essential for lowering costs, improving quality, and expanding access to care for patients.

This action reflects ongoing concerns about market consolidation and its impact on consumer prices. The task force is expected to review both pending transactions and existing market structures, potentially leading to more frequent enforcement actions. Analysts predict this will create a more challenging environment for proposed deals within the health care landscape, as regulators apply heightened scrutiny to any consolidation that may threaten competition.